Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of low molecular weight heparin based nanoparticles for metastatic breast cancer therapy

Published:2018-06 Issue: Volume:112 Page:343-355
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Sun Haifeng,Cao Dinglingge,Wu Hao,Liu Huan,Ke Xue,Ci Tianyuan

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Fundamental Research Funds for the Central Universities

Science and Technology of Jiangsu Province and Public Technology Service Center of Nano drug Preparation and Evaluation of Jiangsu Province

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference57 articles.

1. Tumor metastasis: mechanistic insights and clinical challenges;Steeg;Nat. Med.,2006

2. Dissemination and growth of cancer cells in metastatic sites;Chambers;Nat. Rev. Cancer,2002

3. The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs;Langley;Int. J. Cancer,2011

4. Timeline - the pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited;Fidler;Nat. Rev. Cancer,2003

5. Illuminating the metastatic process;Sahai;Nat. Rev. Cancer,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhaled heparin: Past, present, and future;Drug Discovery Today;2024-08

2. Improving hemocompatibility in tissue-engineered products employing heparin-loaded nanoplatforms;Pharmacological Research;2024-08

3. CD44 targeted-chondroitin sulfate nanoparticles: Fine-tuning hydrophobic groups to enhance in vitro pH-responsiveness and in vivo efficacy for advanced breast cancer treatment;Biomaterials Advances;2024-04

4. Folate-mediated targeting of carrageenan-cholesterol micelles for enhanced breast cancer treatment;European Polymer Journal;2024-03

5. Recent Progression in Controlled Drug Delivery Through Advanced Functional Nanomaterials in Cancer Therapy;BioNanoScience;2024-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3